PharmiWeb.com - Global Pharma News & Resources

Reports - Press Releases

Date Title Company
26-Nov-2024 AI/ML Innovations Inc. Announces Final Private Placement Closing AccessWire
26-Nov-2024 Amphastar Pharmaceuticals to Present at the 36th Annual Piper Sandler Healthcare Conference AccessWire
26-Nov-2024 Beaumont Medical Waste Disposal Company Addresses Surge in Needlestick Injuries With Comprehensive Guide AccessWire
26-Nov-2024 Leading Allergan Trainer Dr. Rubinstein Selected for FDA-Approved BOTOX(R) Cosmetic Treatment of Platysma Bands in Montvale, NJ AccessWire
26-Nov-2024 Revolutionary Epithelium-on Cross-Linking Procedure Offers New Hope for Keratoconus Patients AccessWire
26-Nov-2024 Join Enlivex Therapeutics' Exclusive Live Investor Webinar and Q&A Session on December 3 AccessWire
26-Nov-2024 Taglich Brothers Releases Updated Coverage on Cosmos Health: Projects Positive EPS for 2025 and Sets $3 Price Target, Nearly 300% Above Current Share Price AccessWire
26-Nov-2024 Basketball Star PJ Hall Signs on as sam(R) Brand Ambassador AccessWire
26-Nov-2024 Revolutionizing Healthcare: Lexaria Highlights Expanding Therapeutic Benefits of GLP-1 Drugs AccessWire
26-Nov-2024 Proving the Concept: Aptevo Technology, Pipeline, to Exemplify the Speed and Power of Modular Biotherapeutics at Presentation AccessWire
26-Nov-2024 Unlocking the Mysteries of Consciousness: SIDHE Announces Revolutionary Research Pathways and Transformative Programs AccessWire
26-Nov-2024 Ensysce Biosciences Completes Significant Milestone, Dosing First Subjects in Breakthrough Therapy PF614-MPAR Trial AccessWire
26-Nov-2024 Dr. Alisa Yamasaki Featured in Princeton Health Magazine Discussing Advanced Treatments for Bell's Palsy to Restore Facial Symmetry AccessWire
26-Nov-2024 The End of SDRs? AI Maverick Sales Automation, One Touchpoint at a Time AccessWire
26-Nov-2024 Gold Biotechnology Enhances Visibility and Engagement Through Bioz Partnership AccessWire
25-Nov-2024 Justera Health Revises Vesting Schedule of RSU Grant AccessWire
25-Nov-2024 Medicure Reports Financial Results For Quarter Ended September 30, 2024 AccessWire
25-Nov-2024 Empyrean Therapeutics Acquires TLR-2 Antagonist Molecule From Eos Therapies to Advance and Commercialize Breakthrough Cancer Treatment AccessWire
25-Nov-2024 Juva Life Inc. Updates Shareholders on Court-Appointed Receivership Proceedings AccessWire
25-Nov-2024 Ankle & Foot Centers of America Highlights Vital Role of Podiatric Care for People with Diabetes AccessWire